Recorded fact · drug.trial_access

drug.trial_access for apremilast

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 033c0dfb resolves to.

The record

Fact id	`033c0dfbe0e6cef7bc3e5093`
Entity	drug: apremilast
Field	drug.trial_access
Source	clinicaltrials.gov
Read on	2026-11-07T06:34:32.466Z
Source version	clinicaltrials-api-2.0.5-data-2026-11-06T10:00:05
Method	api
Verification	machine_read
Licence	Terms and Conditions (last updated 2023-01-31) READ in full 2026-11-07: data free to all requesters; reuse allowed on conditions: attribute ClinicalTrials.gov, keep data current, display the date the registry processed the data, state any modifications; do not represent the data as other than a US Government database; no use of extracted email addresses for marketing; some records may carry third-party copyright (consult the submitter) and the data carry an international copyright outside the US. API rate guidance page UNREAD (JS page rendered no text 2026-11-07). AMBER because of the third-party copyright caveat on submitter text; counts and ids are safe, long free text is not reproduced. \| DISPLAY CONDITIONS (any page or delivery using this source): attribute ClinicalTrials.gov, show the registry processing date, state our modifications, never present as other than a US Government database, never use extracted emails for marketing.
Edition	2026-11, Merkle root `006ab9a329709cbe...`

This fact carries no verifying quote; its source is the dataset named above.

The value

{
 "ingredient": "APREMILAST",
 "recruitingInterventionalCount": 10,
 "notYetRecruitingCount": 7,
 "byPhase": {
  "PHASE3": 5,
  "PHASE2": 3,
  "PHASE1": 1,
  "EARLY_PHASE1": 1
 },
 "trials": [
  {
   "nctId": "NCT02735707",
   "briefTitle": "Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "UMC Utrecht",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-11-04",
   "startDate": "2016-04-11",
   "conditions": [
    "Respiratory Tract Diseases",
    "Influenza (Pandemic)",
    "Influenza"
   ],
   "countries": [
    "United States",
    "Australia",
    "Belgium",
    "Canada",
    "Colombia",
    "Croatia",
    "Czechia",
    "Estonia",
    "Finland",
    "France"
   ],
   "url": "https://clinicaltrials.gov/study/NCT02735707"
  },
  {
   "nctId": "NCT05767047",
   "briefTitle": "A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Amgen",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-11-04",
   "startDate": "2023-03-23",
   "conditions": [
    "Behçet's Disease",
    "Juvenile Psoriatic Arthritis"
   ],
   "countries": [
    "Greece",
    "Israel",
    "Spain",
    "Turkey (Türkiye)"
   ],
   "url": "https://clinicaltrials.gov/study/NCT05767047"
  },
  {
   "nctId": "NCT07029529",
   "briefTitle": "Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Yale University",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-30",
   "startDate": "2026-05-12",
   "conditions": [
    "Alcohol Use Disorder"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07029529"
  },
  {
   "nctId": "NCT04804553",
   "briefTitle": "Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Amgen",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-20",
   "startDate": "2022-03-17",
   "conditions": [
    "Active Juvenile Psoriatic Arthritis"
   ],
   "countries": [
    "Belgium",
    "France",
    "Germany",
    "Greece",
    "Italy",
    "Lithuania",
    "Netherlands",
    "Poland",
    "Portugal",
    "Romania"
   ],
   "url": "https://clinicaltrials.gov/study/NCT04804553"
  },
  {
   "nctId": "NCT05703685",
   "briefTitle": "[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET",
   "phase": [
    "PHASE1"
   ],
   "leadSponsor": "National Institute of Mental Health (NIMH)",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-10-01",
   "startDate": "2023-06-22",
   "conditions": [
    "Depression"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT05703685"
  },
  {
   "nctId": "NCT04528082",
   "briefTitle": "Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Amgen",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-07-24",
   "startDate": "2021-09-09",
   "conditions": [
    "Behçet Disease"
   ],
   "countries": [
    "France",
    "Greece",
    "Israel",
    "Italy",
    "Spain",
    "Switzerland",
    "Turkey (Türkiye)",
    "United Kingdom"
   ],
   "url": "https://clinicaltrials.gov/study/NCT04528082"
  },
  {
   "nctId": "NCT07325266",
   "briefTitle": "Human Laboratory Study of Apremilast for Alcohol Use Disorder",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-05-01",
   "startDate": "2026-04-03",
   "conditions": [
    "Alcohol Use Disorder",
    "Alcohol Misuse"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07325266"
  },
  {
   "nctId": "NCT04227314",
   "briefTitle": "Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "University Hospital, Rouen",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-02-17",
   "startDate": "2022-04-10",
   "conditions": [
    "Recurrent Aphtous Stomatitis"
   ],
   "countries": [
    "France"
   ],
   "url": "https://clinicaltrials.gov/study/NCT04227314"
  },
  {
   "nctId": "NCT07337434",
   "briefTitle": "To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital",
   "phase": [
    "EARLY_PHASE1"
   ],
   "leadSponsor": "Syeda Sana Zaman",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-01-13",
   "startDate": "2025-12-25",
   "conditions": [
    "Chronic Plaque Psoriasis"
   ],
   "countries": [
    "Pakistan"
   ],
   "url": "https://clinicaltrials.gov/study/NCT07337434"
  },
  {
   "nctId": "NCT06509984",
   "briefTitle": "A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "Centre Hospitalier Universitaire de Nice",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2025-02-24",
   "startDate": "2024-08-06",
   "conditions": [
    "Epidermolysis Bullosa Simplex",
    "Genodermatosis"
   ],
   "countries": [
    "France"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06509984"
  }
 ],
 "query": {
  "intr": "apremilast",
  "filterOverallStatus": "RECRUITING",
  "filterAdvanced": "AREA[StudyType]INTERVENTIONAL",
  "sort": "LastUpdatePostDate:desc",
  "apiVersion": "2.0.5"
 },
 "attribution": "ClinicalTrials.gov",
 "dataProcessedByRegistry": "2026-11-06T10:00:05",
 "modifications": "Counts and phase tallies computed here from the full recruiting re
... (shortened here; the full value is in the JSON twin)

SHA-256 of the exact stored value: 6fbde2fe1c6935b5e78d8584f81e634588536dac4c32ca27070a22357228990d.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.